A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

Bone Marrow Transplantation

Volumn 24, Issue 6, 1999, Pages 601-607

  Ojeda, E ^a   Garcia Bustos, J ^a   Aguado, M J ^a   Arrieta, R ^a   Quevedo, E ^a   Jimenez Yuste, V ^a   Canales, M ^a   Hernandez Navarro, F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Filgrastim; G CSF; PBSC autotransplantation; Randomized study

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; MORPHINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; BLEEDING; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; GRANULOCYTE; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 0032878048     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701972     Document Type: Article

References (14)

1. Hornedo J, Sola C, Solano C et al. Multicentric, randomized and prospective study about the role of Filgrastim (G-CSF) post-transplantation of hematopoietic progenitors cell mobilized with G-CSF in patients with breast cancer. Sangre 1997; 42 (Suppl. 1): 54-56.
2. Linch DC, Milligan DW, Winfield DA et al. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol 1998; 99: 933-938.
3. Lee SM, Radford JA, Dobson L et al. Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. Br J Cancer 1998; 77: 1294-1299.
4. McQuaker IG, Hunter AE, Pacey S et al. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997; 15: 451-457.
5. Kawano Y, Takaue Y, Mimaya J et al for the Japanese Cooperative Study Group of PBSCT. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. Blood 1998; 92: 4040-4046.
6. Hernández-Navarro F, Ojeda E, Arrieta R et al. Single-centre experience of peripheral blood stem cell transplantation using cryopreservation by immersion in a methanol bath. Bone Marrow Transplant 1995; 16: 71-77.
7. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
8. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
9. Eder JP, Elias A, Shea TC et al. A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. J Clin Oncol 1990; 8: 1239-1245.
10. McMillan AK, Goldstone AH. Autologous bone marrow transplantation for non-Hodgkin's lymphoma. Eur J Hematol 1991; 46: 129-135.
11. Faucher C, Le Corroller AG, Chabannon C et al. Administration of G-CSF can be delayed after transplantation of autologous G-CSF primed blood stem cells: a randomized study. Bone Marrow Transplant 1996; 17: 533-536.
12. Ojeda E, Garcia-Bustos J, Aguado MJ et al. G-CSF after PBSC transplantation. Br J Haematol 1998; 101: 594-595.
13. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
14. Bernstein SH, Nademanee AP, Vose JM et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood 1998; 91: 3509-3517.